Weiqi Hong

机构：Ewha Womans University, Sichuan University, Ewha Womans University Medical Center, State Key Laboratory of Biotherapy · ORCID：0000-0003-1668-2301

发表论文 70 篇 · 总被引 7252 次 · h-index 30

代表论文

• Immunosenescence: signaling pathways, diseases and therapeutic targets (2025 · Signal Transduction and Targeted Therapy · 被引 106)
• Mucosal immunity and vaccination strategies: current insights and future perspectives (2025 · Molecular Biomedicine · 被引 48)
• Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges (2024 · ACS Nano · 被引 44)
• Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform (2024 · Cellular and Molecular Immunology · 被引 20)
• Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials (2024 · Nature Communications · 被引 16)
• Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants (2024 · Signal Transduction and Targeted Therapy · 被引 15)